Phase I study of the novel proteasome inhibitor NPI-0052 in patients with lymphoma and solid tumors Meeting Abstract
| Authors: | Aghajanian, C. A.; Hamlin, P.; Gordon, M. S.; Hong, D. S.; Naing, A.; Younes, A.; Hannah, A.; Palladino, M. A.; Spear, M. A.; Kurzrock, R. |
| Abstract Title: | Phase I study of the novel proteasome inhibitor NPI-0052 in patients with lymphoma and solid tumors |
| Meeting Title: | 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 26 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2008 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2008-05-20 |
| Start Page: | 171s |
| Language: | English |
| ACCESSION: | WOS:000208457401044 |
| DOI: | 10.1200/jco.2008.26.15_suppl.3574 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 3574 -- Source: Wos |
